Search

Author/Creator Kulikowski, E

1. Apabetalone, a BET inhibitor, attenuates inflammation induced by viral RNA mimetic and reduces SARS-CoV-2 spike protein binding regardless of variants. (3rd October 2022)

Authors:
Fu, L; Gilham, D; Stotz, S; Sarsons, C; Rakai, B; Tsujikawa, L; Wasiak, S; Johansson, J; Sweeney, M; Wong, N; Kulikowski, E
Journal:
European heart journal
Issue:
Volume 43(2022)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Apabetalone, a selective BET protein inhibitor, reduces ischemic cardiovascular events and hospitalization for heart failure in patients with acute coronary syndrome and type 2 diabetes. (25th November 2020)

Authors:
Ray, K.K; Nicholls, S.J; Buhr, K.A; Ginsberg, H.N; Kalantar-Zadeh, K; Johansson, J.O; Kulikowski, E; Toth, P.P; Wong, N; Sweeney, M; Schwartz, G.G
Journal:
European heart journal
Issue:
Volume 41:(2020)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Bromodomain and extraterminal (BET) protein inhibitor, apabetalone, reduces ACE2 expression and attenuates SARS-CoV-2 infection in vitro. (14th October 2021)

Authors:
Gilham, D; Smith, A L; Fu, L; Moore, D Y; Muralidharan, A; Reid, S P M; Stotz, S C; Johansson, J O; Sweeney, M; Wong, N C W; El-Gamal, D; Kulikowski, E
Journal:
European heart journal
Issue:
Volume 42(2021)Supplement 1
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Reduction in the risk of MACE with apabetalone in patients with recent acute coronary syndrome and diabetes according to NAFLD fibrosis score: exploratory analysis of the BETonMACE trial. (14th October 2021)

Authors:
Toth, P P; Schwartz, G G; Nicholls, S J; Halliday, C; Ginsberg, H N; Johansson, J O; Kalantar-Zadeh, K; Kulikowski, E; Lebioda, K; Wong, N; Sweeney, M; Ray, K K
Journal:
European heart journal
Issue:
Volume 42(2021)Supplement 1
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗